Sen. Baldwin Presses Trump Administration on Holding Pharmaceutical Companies Accountable for Price Hikes
May 10, 2018
May 10, 2018
WASHINGTON, May 10 -- The office of Sen. Tammy Baldwin, D-Wisconsin, issued the following news release:
On the eve of the President's speech to roll out his plan to address skyrocketing prescription drug prices, U.S. Senator Tammy Baldwin, a member of the Senate Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies, today pressed HHS Secretary Alex Azar to identify specific actions the Trump Administration is taking to bring down the cost of prescription dr . . .
On the eve of the President's speech to roll out his plan to address skyrocketing prescription drug prices, U.S. Senator Tammy Baldwin, a member of the Senate Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies, today pressed HHS Secretary Alex Azar to identify specific actions the Trump Administration is taking to bring down the cost of prescription dr . . .